Torbjörn W. Larsson

CEO appointed 2021.

Torbjörn holds a BSc BA from IHM Business School. He has experience in leadership and international business development from both larger and smaller companies within Life Science and MedTech, including Novo Nordisk Engineering and Doxa. Experience from First North and IPO.

Holdings in the company: 40,000 shares and 40,000 warrants of series TO1


Do you want to know more?

Contact us today.